Literature DB >> 15004804

Mimicking liver iron overload using liposomal ferritin preparations.

John C Wood1, Joe D Fassler, Tom Meade.   

Abstract

Close monitoring of liver iron content is necessary to prevent iron overload in transfusion-dependent anemias. Liver biopsy remains the gold standard; however, MRI potentially offers a noninvasive alternative. Iron metabolism and storage is complicated and tissue/disease-specific. This report demonstrates that iron distribution may be more important than iron speciation with respect to MRI signal changes. Simple synthetic analogs of hepatic lysosomes were constructed from noncovalent attachment of horse-spleen ferritin to 0.4 microm diameter phospholipid liposomes suspended in agarose. Graded iron loading was achieved by varying ferritin burden per liposome as well as liposomal volume fraction. T1 and T2 relaxation times were measured on a 60 MHz NMR spectrometer and compared to simple ferritin-gel combinations. Liposomal-ferritin had 6-fold stronger T2 relaxivity than unaggregated ferritin but identical T1 relaxivity. Liposomal-ferritin T2 relaxivity also more closely matched published results from hemosiderotic marmoset liver, suggesting a potential role as an iron-calibration phantom. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15004804      PMCID: PMC2892965          DOI: 10.1002/mrm.10735

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  20 in total

Review 1.  Noninvasive measurement of iron: report of an NIDDK workshop.

Authors:  Gary M Brittenham; David G Badman
Journal:  Blood       Date:  2002-08-29       Impact factor: 22.113

2.  Transverse relaxation of solvent protons induced by magnetized spheres: application to ferritin, erythrocytes, and magnetite.

Authors:  P Gillis; S H Koenig
Journal:  Magn Reson Med       Date:  1987-10       Impact factor: 4.668

3.  MR relaxation times and iron content of thalassemic spleens: an in vitro study.

Authors:  J M Gomori; R I Grossman; H R Drott
Journal:  AJR Am J Roentgenol       Date:  1988-03       Impact factor: 3.959

Review 4.  Iron overload: causes and consequences.

Authors:  V R Gordeuk; B R Bacon; G M Brittenham
Journal:  Annu Rev Nutr       Date:  1987       Impact factor: 11.848

5.  Magnetic resonance imaging in hemochromatosis: extrahepatic iron deposition.

Authors:  J F Housman; J L Chezmar; R C Nelson
Journal:  Gastrointest Radiol       Date:  1989

6.  Microscopic susceptibility variation and transverse relaxation: theory and experiment.

Authors:  R M Weisskoff; C S Zuo; J L Boxerman; B R Rosen
Journal:  Magn Reson Med       Date:  1994-06       Impact factor: 4.668

7.  Nuclear magnetic resonance imaging of experimentally induced liver disease.

Authors:  D D Stark; N M Bass; A A Moss; B R Bacon; J H McKerrow; C E Cann; A Brito; H I Goldberg
Journal:  Radiology       Date:  1983-09       Impact factor: 11.105

8.  The amount of ferritin and hemosiderin in the livers of patients with iron-loading diseases.

Authors:  F M Zuyderhoudt; J W Sindram; J J Marx; G G Jörning; J van Gool
Journal:  Hepatology       Date:  1983 Mar-Apr       Impact factor: 17.425

9.  Liver iron quantification: studies in aqueous iron solutions, iron overloaded rats, and patients with hereditary hemochromatosis.

Authors:  R Engelhardt; J H Langkowski; R Fischer; P Nielsen; H Kooijman; H C Heinrich; E Bücheler
Journal:  Magn Reson Imaging       Date:  1994       Impact factor: 2.546

10.  Studies of iron overload. Rat liver siderosome ferritin.

Authors:  G W Richter
Journal:  Lab Invest       Date:  1984-01       Impact factor: 5.662

View more
  24 in total

1.  Controlled aggregation of ferritin to modulate MRI relaxivity.

Authors:  Kevin M Bennett; Erik M Shapiro; Christopher H Sotak; Alan P Koretsky
Journal:  Biophys J       Date:  2008-03-07       Impact factor: 4.033

Review 2.  Magnetic resonance imaging measurement of iron overload.

Authors:  John C Wood
Journal:  Curr Opin Hematol       Date:  2007-05       Impact factor: 3.284

3.  Striatal iron content predicts its shrinkage and changes in verbal working memory after two years in healthy adults.

Authors:  Ana M Daugherty; E Mark Haacke; Naftali Raz
Journal:  J Neurosci       Date:  2015-04-29       Impact factor: 6.167

4.  Mechanisms of tissue-iron relaxivity: nuclear magnetic resonance studies of human liver biopsy specimens.

Authors:  Nilesh R Ghugre; Thomas D Coates; Marvin D Nelson; John C Wood
Journal:  Magn Reson Med       Date:  2005-11       Impact factor: 4.668

Review 5.  Modified natural nanoparticles as contrast agents for medical imaging.

Authors:  David P Cormode; Peter A Jarzyna; Willem J M Mulder; Zahi A Fayad
Journal:  Adv Drug Deliv Rev       Date:  2009-11-06       Impact factor: 15.470

6.  History and current impact of cardiac magnetic resonance imaging on the management of iron overload.

Authors:  John C Wood
Journal:  Circulation       Date:  2009-11-02       Impact factor: 29.690

7.  Influence of iron chelation on R1 and R2 calibration curves in gerbil liver and heart.

Authors:  John C Wood; Michelle Aguilar; Maya Otto-Duessel; Hanspeter Nick; Marvin D Nelson; Rex Moats
Journal:  Magn Reson Med       Date:  2008-07       Impact factor: 4.668

Review 8.  Magnetic resonance imaging assessment of excess iron in thalassemia, sickle cell disease and other iron overload diseases.

Authors:  John C Wood; Nilesh Ghugre
Journal:  Hemoglobin       Date:  2008       Impact factor: 0.849

9.  Quantitative effects of cell internalization of two types of ultrasmall superparamagnetic iron oxide nanoparticles at 4.7 T and 7 T.

Authors:  J-C Brisset; V Desestret; S Marcellino; E Devillard; F Chauveau; F Lagarde; S Nataf; N Nighoghossian; Y Berthezene; M Wiart
Journal:  Eur Radiol       Date:  2009-08-25       Impact factor: 5.315

10.  A virtual water maze revisited: Two-year changes in navigation performance and their neural correlates in healthy adults.

Authors:  Ana M Daugherty; Naftali Raz
Journal:  Neuroimage       Date:  2016-09-19       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.